Clinical Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2008; 14(29): 4652-4661
Published online Aug 7, 2008. doi: 10.3748/wjg.14.4652
Table 1 Summary of clinical and demographic data on Caucasian IBD patients genotyped for at least one TNF-α polymorphism n (%)
CDUCIC
Gender38840527
Female249 (64.2)214 (52.8)15 (55.6)
Male139 (35.8)191 (47.2)12 (44.4)
Age at first diagnosis
Below 1739 (10.0)26 (6.4)0
Between 17 and 40199 (51.3)184 (45.4)15 (55.6)
Above 40150 (38.7)195 (48.2)12 (44.4)
CD location
Ileal125 (32.2)
Colonic169 (43.6)
Ileocolonic90 (23.2)
Unknown (U + UN)4 (1.0)
UC location
Proctitis140 (34.6)3 (11.1)
Left colon107 (26.4)5 (18.5)
Pancolitis154 (38.0)19 (70.4)
Unknown4 (1.0)0
Behaviour
Non-structuring, non-penetrating perianal disease: With47 (21.5)
Without172 (78.5)
Structuring perianal disease: With46 (38.0)
Without75 (62.0)
Penetrating perianal disease: With17 (35.4)
Without31 (64.6)
Any relative with IBD: Yes (n = 143)74 (19.1)65 (16.1)5 (18.5)
Bowel resection: Yes (n = 214)142 (36.6)70 (17.3)2 (7.4)
Smoker at diagnosis: Yes (n = 147)97 (25.7)49 (12.3)2 (7.7)
Ever used immunomo- dulators: Yes (n = 296)203 (52.3)86 (21.2)8 (29.6)
Extra intestinal manifestations: Yes (n = 142)75 (19.3)64 (15.8)3 (11.1